378 related articles for article (PubMed ID: 34209646)
1. The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
Gonzalez-Sanchez E; Vaquero J; Férnandez-Barrena MG; Lasarte JJ; Avila MA; Sarobe P; Reig M; Calvo M; Fabregat I
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209646
[TBL] [Abstract][Full Text] [Related]
2. The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications.
Gungor MZ; Uysal M; Senturk S
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205692
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma.
Chen J; Gingold JA; Su X
Trends Mol Med; 2019 Nov; 25(11):1010-1023. PubMed ID: 31353124
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.
Fabregat I; Caballero-Díaz D
Front Oncol; 2018; 8():357. PubMed ID: 30250825
[TBL] [Abstract][Full Text] [Related]
5. TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy.
Arrese M; Hernandez A; Astete L; Estrada L; Cabello-Verrugio C; Cabrera D
Curr Protein Pept Sci; 2018; 19(12):1172-1179. PubMed ID: 29150921
[TBL] [Abstract][Full Text] [Related]
6. The TGF-β signaling pathway as a pharmacological target in a hepatocellular carcinoma.
Mazzocca A; Antonaci S; Giannelli G
Curr Pharm Des; 2012; 18(27):4148-54. PubMed ID: 22630081
[TBL] [Abstract][Full Text] [Related]
7. Validation of Hepatocellular Carcinoma Experimental Models for TGF-β Promoting Tumor Progression.
Mancarella S; Krol S; Crovace A; Leporatti S; Dituri F; Frusciante M; Giannelli G
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31600917
[TBL] [Abstract][Full Text] [Related]
8. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer.
Caballero-Díaz D; Bertran E; Peñuelas-Haro I; Moreno-Càceres J; Malfettone A; López-Luque J; Addante A; Herrera B; Sánchez A; Alay A; Solé X; Serrano T; Ramos E; Fabregat I
J Hepatol; 2020 Jan; 72(1):125-134. PubMed ID: 31562907
[TBL] [Abstract][Full Text] [Related]
9. TGF-β signalling and liver disease.
Fabregat I; Moreno-Càceres J; Sánchez A; Dooley S; Dewidar B; Giannelli G; Ten Dijke P;
FEBS J; 2016 Jun; 283(12):2219-32. PubMed ID: 26807763
[TBL] [Abstract][Full Text] [Related]
10. POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
Wang B; Xu X; Yang Z; Zhang L; Liu Y; Ma A; Xu G; Tang M; Jing T; Wu L; Liu Y
EBioMedicine; 2019 Mar; 41():320-332. PubMed ID: 30745168
[TBL] [Abstract][Full Text] [Related]
11. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.
Rojas A; Zhang P; Wang Y; Foo WC; Muñoz NM; Xiao L; Wang J; Gores GJ; Hung MC; Blechacz B
Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026
[TBL] [Abstract][Full Text] [Related]
12. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
Yamazaki K; Masugi Y; Sakamoto M
Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
[TBL] [Abstract][Full Text] [Related]
14. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
Dooley S; Weng H; Mertens PR
Dig Dis; 2009; 27(2):93-101. PubMed ID: 19546546
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma.
Han M; Liao Z; Liu F; Chen X; Zhang B
Biomark Res; 2020 Dec; 8(1):70. PubMed ID: 33292618
[TBL] [Abstract][Full Text] [Related]
17. TGF-β signaling in onset and progression of hepatocellular carcinoma.
Meindl-Beinker NM; Matsuzaki K; Dooley S
Dig Dis; 2012; 30(5):514-23. PubMed ID: 23108308
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
20. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
